Changeflow GovPing Healthcare & Life Sciences Novel Platelet Derived Growth Factor Peptide Mi...
Routine Notice Added Final

Novel Platelet Derived Growth Factor Peptide Mimetic for Cardiac Repair

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO has published a patent application (US20260085101A1) for a novel platelet-derived growth factor peptide mimetic designed for cardiac repair, particularly post-infarction. The application details specific compounds, their preparation, and methods of use.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO detailing a novel peptide mimetic intended for cardiac repair. The application, titled 'Novel Platelet Derived Growth Factor Peptide Mimetic for Cardiac Repair,' outlines compounds of formula (I) and their methods of preparation and use, specifically for improving cardiac repair post-infarct.

While this is a patent application and not a regulatory rule, it signifies potential future developments in therapeutic agents. Companies involved in cardiovascular drug development, peptide synthesis, or regenerative medicine should be aware of this disclosure as it may impact intellectual property landscapes and future product pipelines. No immediate compliance actions are required, but monitoring patent filings in this area is advisable for strategic planning.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

NOVEL PLATELET DERIVED GROWTH FACTOR PEPTIDE MIMETIC

Application US20260085101A1 Kind: A1 Mar 26, 2026

Inventors

James CHONG, Emily McKINNA, Richard PAYNE, Daniel FORD, Richard HARVEY, Osvaldo CONTRERAS

Abstract

Disclosed herein are compounds of formula (I) wherein X, L1, and HSA conjugate are as defined herein, methods of preparation thereof, and methods of using thereof for improving cardiac repair, particularly post infarct.

CPC Classifications

C07K 14/49 A61K 47/542 A61K 47/643 A61P 9/00 A61P 9/10 A61K 38/00

Filing Date

2023-09-08

Application No.

19109910

View original document →

Named provisions

Inventors Abstract CPC Classifications

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085101A1

Who this affects

Applies to
Drug manufacturers Medical device makers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Development Therapeutic Agent Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!